Combined Modality Therapy
"Combined Modality Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used.
Descriptor ID |
D003131
|
MeSH Number(s) |
E02.186
|
Concept/Terms |
Combined Modality Therapy- Combined Modality Therapy
- Multimodal Treatment
- Multimodal Treatments
- Treatment, Multimodal
- Treatments, Multimodal
- Therapy, Combined Modality
- Combined Modality Therapies
- Modality Therapies, Combined
- Modality Therapy, Combined
- Therapies, Combined Modality
|
Below are MeSH descriptors whose meaning is more general than "Combined Modality Therapy".
Below are MeSH descriptors whose meaning is more specific than "Combined Modality Therapy".
This graph shows the total number of publications written about "Combined Modality Therapy" by people in this website by year, and whether "Combined Modality Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 75 | 75 |
1995 | 0 | 78 | 78 |
1996 | 0 | 72 | 72 |
1997 | 0 | 70 | 70 |
1998 | 1 | 85 | 86 |
1999 | 0 | 90 | 90 |
2000 | 1 | 90 | 91 |
2001 | 2 | 99 | 101 |
2002 | 0 | 82 | 82 |
2003 | 1 | 156 | 157 |
2004 | 1 | 143 | 144 |
2005 | 0 | 149 | 149 |
2006 | 1 | 163 | 164 |
2007 | 2 | 161 | 163 |
2008 | 1 | 169 | 170 |
2009 | 2 | 159 | 161 |
2010 | 2 | 174 | 176 |
2011 | 4 | 143 | 147 |
2012 | 1 | 112 | 113 |
2013 | 7 | 133 | 140 |
2014 | 3 | 120 | 123 |
2015 | 3 | 136 | 139 |
2016 | 7 | 177 | 184 |
2017 | 6 | 158 | 164 |
2018 | 4 | 140 | 144 |
2019 | 8 | 148 | 156 |
2020 | 3 | 129 | 132 |
2021 | 2 | 73 | 75 |
2022 | 0 | 30 | 30 |
2023 | 0 | 40 | 40 |
2024 | 0 | 11 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Combined Modality Therapy" by people in Profiles.
-
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE-716 trial. J Immunother Cancer. 2024 Mar 13; 12(3).
-
Local and Systemic Management Options for Melanoma Brain Metastases. Cancer J. 2024 Mar-Apr 01; 30(2):102-107.
-
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy. J Immunother Cancer. 2024 Feb 29; 12(2).
-
Reconciling the discrepancies in randomized data of combining immunotherapy and radiation therapy: Not all radiotherapy is created equal. Eur J Cancer. 2024 Apr; 201:113972.
-
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C?melanoma is removed by surgery. Future Oncol. 2024 May; 20(15):959-968.
-
Pan-cancer proteogenomics characterization of tumor immunity. Cell. 2024 Feb 29; 187(5):1255-1277.e27.
-
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients". Radiother Oncol. 2024 Apr; 193:110138.
-
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative. Ann Surg Oncol. 2024 May; 31(5):3314-3324.
-
Updated Analysis of a Phase 2 Trial of Cytoreduction, Gastrectomy, and Hyperthermic Intraperitoneal Perfusion with Chemotherapy for Patients with Peritoneal Carcinoma from Gastric Cancer. Ann Surg Oncol. 2024 May; 31(5):2824-2825.
-
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives. Int J Radiat Oncol Biol Phys. 2024 Apr 01; 118(5):1404-1421.